The emerging therapy of this peptide represents a major advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide502093.idblogz.com/42421694/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment